LEPR

protein-coding

leptin receptor, the group of CD molecules|Immunoglobulin like domain containing

Gene summary

The protein encoded by this gene belongs to the gp130 family of cytokine receptors that are known to stimulate gene transcription via activation of cytosolic STAT proteins. This protein is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this gene have been associated with obesity and pituitary dysfunction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. It is noteworthy that this gene and LEPROT gene (GeneID:54741) share the same promoter and the first 2 exons, however, encode distinct proteins (PMID:9207021).[provided by RefSeq, Nov 2010]

MANE transcript

NM_002303.6

Inheritance

AR

ClinVar variants

P:55U:327B:154

Top phenotype

Leptin receptor deficiency

gnomAD constraint

pLI —, LoF o/e 0.16

Max pathogenic AF

—

Genomic locus

chr1:65,420,652-65,641,559

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~220.9 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

obesity due to leptin receptor gene deficiencySUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013992

Submitter: Orphanet

obesity due to leptin receptor gene deficiencySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013992

Submitter: Labcorp Genetics (formerly Invitae)

obesity due to leptin receptor gene deficiencySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013992

Submitter: Genomics England PanelApp

obesity due to leptin receptor gene deficiencySTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013992

Submitter: PanelApp Australia

Clinical Genomic Database (CGD)

Leptin receptor deficiencyAR

Manifestation: Allergy/Immunology/Infectious; Endocrine

Intervention: Allergy/Immunology/Infectious; Endocrine

Rationale: In addition to endocrine manifestations, individuals may be susceptible to infections (eg, respiratory infections), which, coupled with other manifestations (eg, severe obesity) can have severe sequelae such that prophylaxis and rapid treatment may be beneficial; Medical management of obesity with melanocortin-4 receptor (MC4R) agonist (setmelanotide) may be beneficial

Comments: Standard treatments for obesity, such as gastric surgery, have been described as beneficial

Refs: 8666155; 9537324; 17229951; 21306929; 23275530; 23616257; 35528826Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to LEPR variants in ClinVar

13 Conditions Cataloged
LEPR-related disorderTotal: 479
not providedTotal: 157
Inborn genetic diseasesTotal: 97
Obesity due to leptin receptor gene deficiencyTotal: 59
not specifiedTotal: 44
Monogenic diabetesTotal: 13
Early onset severe obesityTotal: 6
ObesityTotal: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_002303.6. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
12
clinvar
116
clinvar
3
clinvar
131
missense
1
clinvar
11
clinvar
308
clinvar
34
clinvar
1
clinvar
355
nonsense
5
clinvar
12
clinvar
1
clinvar
18
start loss
1
clinvar
1
frameshift
6
clinvar
10
clinvar
3
clinvar
19
splice donor/acceptor (+/-2bp)
3
clinvar
6
clinvar
3
clinvar
12
Total15403271504536

Highest pathogenic variant AF is 0.00038719253

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 26 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_002303.6RefSeqNP_002294.218MANE Select
ENST00000349533.11EnsemblENSP00000330393.718MANE Select
NM_001003679.3RefSeqNP_001003679.118Standard
NM_001003680.3RefSeqNP_001003680.118Standard

Model Organisms & Knockout Phenotypes

Observed phenotypic effects in mouse and zebrafish models

Gene / ModelOrganismObserved Phenotype
leprDanio rerio

Structure: secondary motor neuron

Quality: branchiness

abnormal

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Adipocytokine signaling pathway - Homo sapiens (human)
  • Non-alcoholic fatty liver disease (NAFLD) - Homo sapiens (human)
  • Jak-STAT signaling pathway - Homo sapiens (human)
  • AMPK signaling pathway - Homo sapiens (human)
  • Neuroactive ligand-receptor interaction - Homo sapiens (human)

Biological Process

  • angiogenesis
  • energy reserve metabolic process
  • phagocytosis
  • cell surface receptor signaling pathway
  • multicellular organism development

Molecular Function

  • transmembrane signaling receptor activity
  • cytokine receptor activity
  • protein binding
  • peptide hormone binding
  • cytokine binding

Cellular Component

  • extracellular region
  • external side of plasma membrane
  • integral component of membrane
  • basolateral plasma membrane
  • receptor complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000349533
Coding exons
18
Length
220995
Individuals with no LoFs
125718
Homozygous LoFs
0
Heterozygous LoFs
28
Defined
125746
p
0.000111
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.424905870.8350.00002757702
Missense (PolyPhen)88133.570.658851797
Synonymous0.2662042090.9770.00001032122
Loss of Function5.77955.30.1630.00000242755

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000190.00018rare
Latino/Admixed American0.0000870.000087rare
Ashkenazi Jewish00.0absent
East Asian0.000110.00011rare
Finnish0.000140.00014rare
European (Non-Finnish)0.000120.00012rare
South Asian0.0000980.000098rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Receptor for hormone LEP/leptin (Probable) (PubMed:22405007). On ligand binding, mediates LEP central and peripheral effects through the activation of different signaling pathways such as JAK2/STAT3 and MAPK cascade/FOS. In the hypothalamus, LEP acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones (By similarity) (PubMed:9537324). In the periphery, increases basal metabolism, influences reproductive function, regulates pancreatic beta-cell function and insulin secretion, is pro-angiogenic and affects innate and adaptive immunity (PubMed:25060689, PubMed:12504075, PubMed:8805376). Control of energy homeostasis and melanocortin production (stimulation of POMC and full repression of AgRP transcription) is mediated by STAT3 signaling, whereas distinct signals regulate NPY and the control of fertility, growth and glucose homeostasis. Involved in the regulation of counter- regulatory response to hypoglycemia by inhibiting neurons of the parabrachial nucleus. Has a specific effect on T lymphocyte responses, differentially regulating the proliferation of naive and memory T -ells. Leptin increases Th1 and suppresses Th2 cytokine production (By similarity). {ECO:0000250|UniProtKB:P48356, ECO:0000269|PubMed:12504075, ECO:0000269|PubMed:22405007, ECO:0000269|PubMed:25060689, ECO:0000269|PubMed:8805376, ECO:0000269|PubMed:9537324, ECO:0000305|PubMed:25232147}.; FUNCTION: Isoform E: Antagonizes Isoform A and isoform B-mediated LEP binding and endocytosis. {ECO:0000250|UniProtKB:P48356}.;
Disease
DISEASE: Leptin receptor deficiency (LEPRD) [MIM:614963]: A rare disease characterized by normal levels of serum leptin, hyperphagia and severe obesity from an early age. Additional features include alterations in immune function, and delayed puberty due to hypogonadotropic hypogonadism. {ECO:0000269|PubMed:25751111, ECO:0000269|PubMed:9537324}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.0824

Intolerance Scores

LoFtool
0.609
RVIS EVS
-0.22
RVIS percentile EVS
37.7

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.964

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.